Vitamin D receptor expression as a potential marker of malignant transformation in gestational trophoblastic disease
نویسندگان
doi
10.48309/jmpcr.2026.559339.1895چکیده
Aberrant cell cycle regulation is implicated in the transformation of hydatidiform mole into gestational trophoblastic neoplasia. Vitamin D, through its action on the vitamin D receptor, is involved in cell cycle regulation. This study measures the differences in vitamin D receptor expression between hydatidiform mole and gestational trophoblastic neoplasia. This case-control study involved specimens from 13 subjects with hydatidiform mole and 12 subjects with gestational trophoblastic neoplasia, which underwent immunohistochemical staining for the vitamin D receptor. Subsequent color deconvolution of immunohistochemical staining was conducted using ImageJ, and differential expression was analyzed. The average age of subjects with hydatidiform mole and gestational trophoblastic neoplasia was 31.38 ± 10.05 years and 36.08 ± 6.79 years, respectively (p = 0.188). The average serum hCG level in hydatidiform mole and gestational trophoblastic neoplasia was 1,240,425 ± 289,957 mIU/mL and 560,236.9 ± 477,106.9 mIU/mL, respectively (p = 0.431). Significantly lower expression of the vitamin D receptor was observed in gestational trophoblastic neoplasia compared with hydatidiform mole (2.58 ± 0.41 vs. 3.36 ± 0.51; p < 0.001). Lower expression of the vitamin D receptor in gestational trophoblastic neoplasia is associated with malignant transformation and may facilitate the proliferation of trophoblastic tissue. VDR expression represents a potential marker for distinguishing benign from malignant gestational trophoblastic disease .